fda glp-1 compounding enforcement september 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Crackdown on Compounded GLP-1

Trisulfide oral-administration to mice (in vivo experiments) Effect of glutathione trisulfide (GSSSG) and lipoic acid trisulfide (LASSS) pre-administration on muscle disuse-induced nitration of ECM-bound HGF 64 was evaluated by direct-immunofluorescence microscopy with HiLyte Fluor 647-labeled anti-nitroY198-HGF mAb (clone 3A11C6,fluorescent false-yellow)

Hippo pathway-manipulating neutrophil-mimic hybrid nanoparticles for cardiac ischemic injury via modulation of local immunity and cardiac regeneration

Risk of Overdose and Contamination Self-administering smaller doses carries the risk of overdose if a patient miscalculates or adjusts the dose incorrectly

That is clinically meaningful for a specific subset of patients

Despite lots of big lingering questions, many clinicians dont think it actually matters right now how GLP-1 interacts with brain receptors on a cellular level, says Laura Huckins, PhD, an associate professor of psychiatry at the Yale School of Medicine